Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report

Dig Liver Dis. 2007 Sep:39 Suppl 1:S134-5. doi: 10.1016/s1590-8658(07)80026-0.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Cryoglobulinemia / drug therapy*
  • Female
  • Hepatitis C, Chronic / complications*
  • Humans
  • Immunologic Factors / adverse effects
  • Immunologic Factors / therapeutic use*
  • Middle Aged
  • Pneumonia, Bacterial / etiology
  • Rituximab
  • Syndrome
  • Vasculitis / drug therapy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab